Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Inventory (2016 - 2025)

Jaguar Health (JAGX) has disclosed Inventory for 11 consecutive years, with $10.6 million as the latest value for Q3 2025.

  • On a quarterly basis, Inventory rose 9.86% to $10.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was $10.6 million, a 9.86% increase, with the full-year FY2024 number at $10.3 million, up 12.58% from a year prior.
  • Inventory was $10.6 million for Q3 2025 at Jaguar Health, down from $10.7 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $10.7 million in Q2 2025 to a low of $2.8 million in Q1 2021.
  • A 5-year average of $8.0 million and a median of $8.5 million in 2023 define the central range for Inventory.
  • Peak YoY movement for Inventory: rose 4.33% in 2021, then surged 98.27% in 2022.
  • Jaguar Health's Inventory stood at $4.9 million in 2021, then surged by 43.35% to $7.0 million in 2022, then skyrocketed by 30.82% to $9.2 million in 2023, then grew by 12.58% to $10.3 million in 2024, then grew by 2.74% to $10.6 million in 2025.
  • Per Business Quant, the three most recent readings for JAGX's Inventory are $10.6 million (Q3 2025), $10.7 million (Q2 2025), and $10.6 million (Q1 2025).